Chugai Taps Roche Group Member for Board
This article was originally published in PharmAsia News
Executive Summary
Japan-based Chugai will appoint Roche's director of pharma international to its board, the firm announced Jan. 11. Christopher Murray will serve as a special advisory until his appointment as executive vice president at Chugai's board of directors meeting in March. Murray, who joined Roche Hong Kong in 1976, is the pharma division delegate to Roche Group's Corporate Sustainability Committee, which is tasked with developing and coordinating the Group's sustainable development strategies
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)